Avecho Biotechnology Ltd banner

Avecho Biotechnology Ltd
ASX:AVE

Watchlist Manager
Avecho Biotechnology Ltd Logo
Avecho Biotechnology Ltd
ASX:AVE
Watchlist
Price: 0.009 AUD -5.26% Market Closed
Market Cap: AU$33.1m

Avecho Biotechnology Ltd
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avecho Biotechnology Ltd
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Avecho Biotechnology Ltd
ASX:AVE
Other
-AU$187.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Other
-AU$186.1k
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Other
AU$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Other
-AU$37k
CAGR 3-Years
-164%
CAGR 5-Years
49%
CAGR 10-Years
-12%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Other
-AU$193.4k
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Other
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Avecho Biotechnology Ltd
Glance View

Market Cap
33.1m AUD
Industry
Pharmaceuticals

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, and Veterinary Applications. The firm's segments include Production and Personal Care and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches. The Human Health segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

AVE Intrinsic Value
0.006 AUD
Overvaluation 38%
Intrinsic Value
Price

See Also

What is Avecho Biotechnology Ltd's Other?
Other
-187.2k AUD

Based on the financial report for Dec 31, 2025, Avecho Biotechnology Ltd's Other amounts to -187.2k AUD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett